Quadid® B

Beclomethasone, Clotrimazole and Neomycin cream.

Composition

Beclomethasone dipropionate IP 0.025% w/w,
Clotrimazole IP 1% w/w,
Neomycin sulphate IP 0.5% w/w, 
Quadid® B cream contains the active compound beclomethasone dipropionate (a synthetic corticosteroid), Clotrimazole (an imidazole antifungal) and Neomycin (an aminoglycoside antibiotic) for topical dermatologic use.

Indications

Quadid® B Cream is indicated for the relief of the inflammatory manifestations of corticosteroid responsive dermatoses when complicated by secondary infection caused by organisms sensitive to the components of this dermatologic  preparation or when the possibility of such infection is suspected. Such disorders include : Chronic dermatitis of the extremities, balanoposthitis, eczematoid dermatitis, contact dermatitis, follicular dermatitis, parakeratosis, paronychia, anal pruritus, intertrigo, impetigo, neurodermatitis, angular stomatitis, photosensitivity dermatitis, lichenified inquinal dermatophytosis and tinea infections such as tinea pedis, tinea cruris and tinea corporis. 

As with other highly active corticosteroids, therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.

PRESENTATION & PACKAGING

Quadid® B  15 gms collapsible tubes

For Precautions and Drug Interactions please consult full Product Information or write to us.

® - Registered Trade Mark of Quality Innovations and Pharmaceuticals (India) Pvt Ltd.

Disclaimer

 The drug information is intended for the use of a registered medical practitioner only. If you are not a medical professional, you should note that this document does not provide professional medical advice and is not intended to replace personal consultation with a qualified physician and should not be relied upon solely for final treatment decisions. Company reserves right to change Product presentation, display, capsule colors, tablet size,forms etc without prior notice.